Healthcare of Ontario Pension Plan Trust Fund lifted its stake in Quaker Chemical Co. (NYSE:KWR - Free Report) by 9.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 80,400 shares of the specialty chemicals company's stock after acquiring an additional 6,900 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned 0.45% of Quaker Chemical worth $13,547,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. First Pacific Financial purchased a new stake in shares of Quaker Chemical during the second quarter valued at about $25,000. GAMMA Investing LLC raised its stake in shares of Quaker Chemical by 105.3% during the 3rd quarter. GAMMA Investing LLC now owns 156 shares of the specialty chemicals company's stock worth $26,000 after acquiring an additional 80 shares in the last quarter. Fifth Third Bancorp lifted its position in Quaker Chemical by 36.8% during the second quarter. Fifth Third Bancorp now owns 286 shares of the specialty chemicals company's stock valued at $49,000 after acquiring an additional 77 shares during the last quarter. KBC Group NV boosted its stake in Quaker Chemical by 50.9% in the third quarter. KBC Group NV now owns 525 shares of the specialty chemicals company's stock valued at $88,000 after acquiring an additional 177 shares in the last quarter. Finally, nVerses Capital LLC purchased a new position in Quaker Chemical in the second quarter worth $136,000. Institutional investors own 77.46% of the company's stock.
Analyst Upgrades and Downgrades
KWR has been the subject of several analyst reports. Royal Bank of Canada decreased their price objective on Quaker Chemical from $195.00 to $180.00 and set an "outperform" rating for the company in a report on Monday, November 4th. StockNews.com raised Quaker Chemical from a "hold" rating to a "buy" rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft lowered their price target on Quaker Chemical from $190.00 to $182.00 and set a "buy" rating for the company in a report on Monday, November 4th. Finally, Piper Sandler upped their price objective on shares of Quaker Chemical from $190.00 to $200.00 and gave the company an "overweight" rating in a report on Friday, November 8th.
View Our Latest Report on KWR
Quaker Chemical Stock Performance
Shares of NYSE:KWR traded up $1.84 on Friday, hitting $157.70. 75,869 shares of the company were exchanged, compared to its average volume of 96,021. The firm has a market capitalization of $2.81 billion, a P/E ratio of 23.12, a price-to-earnings-growth ratio of 1.88 and a beta of 1.38. The company has a current ratio of 2.54, a quick ratio of 1.88 and a debt-to-equity ratio of 0.48. Quaker Chemical Co. has a 1-year low of $151.31 and a 1-year high of $221.94. The stock's 50 day moving average price is $163.01 and its 200 day moving average price is $169.28.
Quaker Chemical (NYSE:KWR - Get Free Report) last issued its earnings results on Thursday, October 31st. The specialty chemicals company reported $1.89 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.08 by ($0.19). The firm had revenue of $462.27 million during the quarter, compared to analysts' expectations of $469.17 million. Quaker Chemical had a return on equity of 10.10% and a net margin of 6.58%. The business's revenue was down 5.8% on a year-over-year basis. During the same quarter last year, the business earned $2.05 EPS. Sell-side analysts predict that Quaker Chemical Co. will post 7.78 EPS for the current year.
Quaker Chemical Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, January 17th will be issued a $0.485 dividend. The ex-dividend date of this dividend is Friday, January 17th. This represents a $1.94 annualized dividend and a yield of 1.23%. Quaker Chemical's dividend payout ratio (DPR) is presently 28.45%.
Insiders Place Their Bets
In related news, SVP David Slinkman sold 1,700 shares of the firm's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $167.80, for a total transaction of $285,260.00. Following the sale, the senior vice president now directly owns 2,825 shares of the company's stock, valued at $474,035. This trade represents a 37.57 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Jeewat Bijlani sold 645 shares of Quaker Chemical stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $165.98, for a total value of $107,057.10. Following the transaction, the executive vice president now owns 4,747 shares of the company's stock, valued at approximately $787,907.06. This represents a 11.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.30% of the stock is currently owned by insiders.
About Quaker Chemical
(
Free Report)
Quaker Chemical Corporation, together with its subsidiaries, develops, produces, and markets various formulated specialty chemical products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals.
Read More
Before you consider Quaker Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quaker Chemical wasn't on the list.
While Quaker Chemical currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.